Expanded access experience with anti-CD20 radiolabeled monoclonal antibodies for the treatment of B-cell lymphoma.

被引：0
|
作者：
Dillman, RO
Hurwitz, RR
Lyons, KK
Taketa, RM
Jerjian, KA
Hendrix, C
Holt, A
DeLeon, C
O'Connor, AA
Morrelli, LA
机构：
[1] Hoag Canc Ctr, Newport Beach, CA USA
[2] Hoag Mem Hosp Presbyterian, Newport Beach, CA USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4751
引用
收藏
页码：236B / 236B
页数：1
相关论文
共 50 条
  • [41] Immunotherapeutic mechanisms of anti-CD20 monoclonal antibodies
    Taylor, Ronald P.
    Lindorfer, Margaret A.
    CURRENT OPINION IN IMMUNOLOGY, 2008, 20 (04) : 444 - 449
  • [42] Hematological and Metabolical Changes Following Treatment with Radiolabeled anti-CD20 Antibody for Lymphoma
    Bural, G. G.
    Shrikanthan, S.
    Berkowitz, A.
    Schuster, S.
    Alavi, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S25 - S25
  • [43] TREATMENT OF ADVANCED B-CELL LYMPHOMA WITH MONOCLONAL ANTI-IDIOTYPE ANTIBODIES
    HEKMAN, A
    HONSELAAR, A
    RANKIN, EM
    BRITISH JOURNAL OF CANCER, 1985, 52 (04) : 668 - 668
  • [44] TREATMENT OF B-CELL LYMPHOMA WITH MONOCLONAL ANTI-IDIOTYPE (ID) ANTIBODIES
    MILLER, R
    BROWN, S
    LEVY, R
    BRITISH JOURNAL OF CANCER, 1989, 59 (02) : 310 - 311
  • [45] Anti-CD20 Antibody Therapy for B-Cell Lymphomas
    Calcagno, Andrea
    Rostagno, Roberto
    Di Perri, Giovanni
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (09): : 877 - 878
  • [46] Anti-CD20 Antibody Therapy for B-Cell Lymphomas
    Maloney, David G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (21): : 2008 - 2016
  • [47] Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model
    Green, Damian J.
    Shadman, Mazyar
    Jones, Jon C.
    Frayo, Shani L.
    Kenoyer, Aimee L.
    Hylarides, Mark D.
    Hamlin, Donald K.
    Wilbur, D. Scott
    Balkan, Ethan R.
    Lin, Yukang
    Miller, Brian W.
    Frost, Sofia H. L.
    Gopal, Ajay K.
    Orozco, Johnnie J.
    Gooley, Theodore A.
    Laird, Kelly L.
    Till, Brian G.
    Back, Tom
    Sandmaier, Brenda M.
    Pagel, John M.
    Press, Oliver W.
    BLOOD, 2015, 125 (13) : 2111 - 2119
  • [48] Intralesional therapy with anti-CD20 monoclonal antibody rituximab: local and systemic efficacy in primary cutaneous B-cell lymphoma
    Roguedas, AM
    Watier, H
    Paintaud, G
    de Muret, A
    Vaillant, L
    Machet, L
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (03) : 541 - 544
  • [49] Three different B-cell depletion (anti-CD20 monoclonal antibodies) treatments for severe resistant systemic lupus erythematosus
    Faria, R. M.
    Isenberg, D. A.
    LUPUS, 2010, 19 (10) : 1256 - 1257
  • [50] Polatuzumab vedotin, venetoclax, and an anti-CD20 monoclonal antibody in relapsed/refractory B-cell non-Hodgkin lymphoma
    Yuen, Sam
    Phillips, Tycel J.
    Bannerji, Rajat
    Marlton, Paula
    Gritti, Giuseppe
    Seymour, John F.
    Johnston, Anna
    Arthur, Christopher
    Dodero, Anna
    Sharma, Sunil
    Hirata, Jamie
    Musick, Lisa
    Flowers, Christopher R.
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (07) : 1281 - 1289
12345